Markers reasonable to monitor If a clinician is overseeing research-context use, baseline and periodic checks that have appeared in published AOD-9604 monitoring include: - Weight, waist circumference, and body composition
[PubMed] [Google Scholar] 115.Huang B.S., Huang S.C., Chen F.H., Chang Y., Mei H.F., Huang H.Y., Chen W.Y., Pang J.S
The clinical trials showed steady weight loss progression through 68 weeks, with the most rapid loss occurring between weeks 8 and 32
Sleep quality, stress management, and hormonal health also impact metabolic responsiveness to the peptide
Top Benefits: Enhances weight loss beyond GLP-1 alone Improves insulin response and glucose stability Boosts overall metabolic performance Once-weekly injectable therapy that mimics the natural GLP-1 hormone to improve appetite control and metabolic efficiency